# Anastasiya Giarletta

> Anastasiya Giarletta is a seed investor at R42 Group backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [R42 Group](https://shizune.co/investors/profile/r42-group)
- Total investments: 2
- Last investment: Jun 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/anastasiyakgiarletta

Anastasiya Giarletta is a seed investor at R42 Group focused on Health Care and Biotechnology. Anastasiya Giarletta

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $2.5M | Seed | Jun 09, 2022 |  |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $1.8M | Seed | Mar 05, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 2 deals together
- [Emerging Longevity Ventures](https://shizune.co/investors/profile/emerging-longevity-ventures) — VC Fund, 2 deals together
- [Longevitytech.fund](https://shizune.co/investors/profile/longevitytech-fund) — VC Fund, 2 deals together
- [QantX](https://shizune.co/investors/profile/qantx) — VC Fund, 2 deals together
- [Trend Investment Group](https://shizune.co/investors/profile/trend-investment-group) — VC Fund, 2 deals together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 1 deal together

## About R42 Group

VC Fund · Stanford, United States

R42 Group actively invents and finances deep science ventures. R42 Group will work from the pre-seed inventing stage through to the growth stage.

3 contacts available at R42 Group.

| Name | Title | Profile |
| --- | --- | --- |
| Anastasiya Giarletta | Principal | https://shizune.co/investors/profile/anastasiya-giarletta |
| Indu Navar | Limited Partner | https://shizune.co/investors/profile/indu-navar-ba22 |
| Ronjon Nag | Founder, MD & President | https://shizune.co/investors/profile/ronjon-nag |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Anastasiya Giarletta invest in?

Anastasiya Giarletta invests primarily in Health Care and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Anastasiya Giarletta last invest?

The most recent investment recorded for Anastasiya Giarletta closed in Jun 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co